title: Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.
abstract: Cisplatin, a platinating agent commonly used to treat several cancers, is associated with nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better understanding of the genetic variants associated with cisplatin-induced toxicity, we present a stepwise approach integrating genotypes, gene expression, and sensitivity of HapMap cell lines to cisplatin. Cell lines derived from 30 trios of European descent (CEU) and 30 trios of African descent (YRI) were used to develop a preclinical model to identify genetic variants and gene expression that contribute to cisplatin-induced cytotoxicity in two different populations. Cytotoxicity was determined as cell-growth inhibition at increasing concentrations of cisplatin for 48 h. Gene expression in 176 HapMap cell lines (87 CEU and 89 YRI) was determined using the Affymetrix GeneChip Human Exon 1.0 ST Array. We identified six, two, and nine representative SNPs that contribute to cisplatin-induced cytotoxicity through their effects on 8, 2, and 16 gene expressions in the combined, Centre d'Etude du Polymorphisme Humain (CEPH), and Yoruban populations, respectively. These genetic variants contribute to 27%, 29%, and 45% of the overall variation in cell sensitivity to cisplatin in the combined, CEPH, and Yoruban populations, respectively. Our whole-genome approach can be used to elucidate the expression of quantitative trait loci contributing to a wide range of cellular phenotypes.
authors: Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
authors: R Stephanie
authors: RS
authors: Huang
authors: Shiwei
authors: S
authors: Duan
authors: Sunita J
authors: SJ
authors: Shukla
authors: Emily O
authors: EO
authors: Kistner
authors: Tyson A
authors: TA
authors: Clark
authors: Tina X
authors: TX
authors: Chen
authors: Anthony C
authors: AC
authors: Schweitzer
authors: John E
authors: JE
authors: Blume
authors: M Eileen
authors: ME
authors: Dolan
mesh_terms: D000970:Antineoplastic Agents / Q000633:toxicity*; D044383:Black People / Q000235:genetics; D002460:Cell Line; D002945:Cisplatin / Q000633:toxicity*; D015870:Gene Expression; D015894:Genome, Human; D005838:Genotype; D006801:Humans; D020128:Inhibitory Concentration 50; D020411:Oligonucleotide Array Sequence Analysis; D020641:Polymorphism, Single Nucleotide; D040641:Quantitative Trait Loci; D044465:White People / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin
references: Am J Hum Genet. 2000 Jan;66(1):279-92
references: 10631157
references: Mol Cancer Ther. 2007 Jan;6(1):31-6
references: 17237264
references: Nat Rev Cancer. 2003 Jul;3(7):517-25
references: 12835671
references: Int J Clin Oncol. 2003 Jun;8(3):156-61
references: 12851839
references: Mol Biol Cell. 2003 Jul;14(7):2876-89
references: 12857871
references: Drugs. 2003;63(15):1549-63
references: 12887262
references: Biostatistics. 2003 Apr;4(2):249-64
references: 12925520
references: Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):328-33
references: 14502062
references: Oncogene. 2003 Oct 20;22(47):7265-79
references: 14576837
references: Cancer Res. 2004 Jun 15;64(12):4353-6
references: 15205351
references: Clin Cancer Res. 2004 Aug 1;10(15):4939-43
references: 15297394
references: Radiat Res. 2004 Aug;162(2):128-35
references: 15387139
references: Dan Med Bull. 1990 Feb;37(1):1-12
references: 2178884
references: Crit Rev Oncol Hematol. 2005 Jan;53(1):3-11
references: 15607931
references: Clin Cancer Res. 2005 Feb 15;11(4):1534-8
references: 15746057
references: Nat Rev Drug Discov. 2005 Apr;4(4):307-20
references: 15789122
references: Biochim Biophys Acta. 2005 Jun 30;1744(2):89-92
references: 15950749
references: Chembiochem. 2005 Jul;6(7):1157-66
references: 15934047
references: Clin Oncol (R Coll Radiol). 2005 Jun;17(4):249-57
references: 15997920
references: Oncogene. 2005 Sep 8;24(40):6090-100
references: 15940259
references: Nature. 2005 Oct 27;437(7063):1299-320
references: 16255080
references: Biochem Pharmacol. 2006 Jan 12;71(3):239-47
references: 16325149
references: J Biol Chem. 2005 Dec 30;280(52):42994-9
references: 16157594
references: Int J Gynecol Cancer. 2006 Mar-Apr;16(2):690-7
references: 16681749
references: Oncol Rep. 2006 Aug;16(2):381-7
references: 16820919
references: Anticancer Drugs. 2007 Feb;18(2):161-70
references: 17159602
references: J Cell Physiol. 2002 Jul;192(1):1-15
references: 12115731